[1]
B. Corona Prandi, M. P Rosim, G. Ogata Pedro, e M. Papadimitropoulos, “Cost per number needed to treat and treatment cost of baricitinib versus adalimumab on rheumatoid arthritis treatment in the brazilian private healthcare system ”, J Assist Farm Farmacoecon, vol. 4, nº s.1, fev. 2023.